Enterohemorrhagic Escherichia coli O157:H7 gal mutants are sensitive to bacteriophage P1 and defective in intestinal colonization.
Enterohemorrhagic Escherichia coli (EHEC), especially E. coli O157:H7, is an emerging cause of food-borne illness. Unfortunately, E. coli O157 cannot be genetically manipulated using the generalized transducing phage P1, presumably because its extensive O antigen obscures the P1 receptor, the lipopolysaccharide (LPS) core subunit. The GalE, GalT, GalK, and GalU proteins are necessary for modifying galactose before it can be assembled into the repeating subunit of the O antigen. Here, we constructed E. coli O157:H7 gal mutants which presumably have little or no O antigen. These strains were able to adsorb P1. P1 lysates grown on the gal mutant strains could be used to move chromosomal markers between EHEC strains, thereby facilitating genetic manipulation of E. coli O157:H7. The gal mutants could easily be reverted to a wild-type Gal(+) strain using P1 transduction. We found that the O157:H7 galETKM::aad-7 deletion strain was 500-fold less able to colonize the infant rabbit intestine than the isogenic Gal(+) parent, although it displayed no growth defect in vitro. Furthermore, in vivo a Gal(+) revertant of this mutant outcompeted the galETKM deletion strain to an extent similar to that of the wild type. This suggests that the O157 O antigen is an important intestinal colonization factor. Compared to the wild type, EHEC gal mutants were 100-fold more sensitive to a peptide derived from bactericidal permeability-increasing protein, a bactericidal protein found on the surface of intestinal epithelial cells. Thus, one way in which the O157 O antigen may contribute to EHEC intestinal colonization is to promote resistance to host-derived antimicrobial polypeptides.
Ho
Theresa Deland
TD
Department of Molecular Biology and Microbiology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA.
Waldor
Matthew K
MK
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D023181:Antimicrobial Cationic Peptides / Q000494:pharmacology; D001433:Bacteriolysis; D017101:Bacteriophage P1 / Q000254:growth & development*; D001798:Blood Proteins / Q000494:pharmacology; D004927:Escherichia coli Infections / Q000382:microbiology; D019453:Escherichia coli O157 / Q000235:genetics / Q000472:pathogenicity* / Q000821:virology*; D029968:Escherichia coli Proteins / Q000235:genetics* / Q000502:physiology; D017353:Gene Deletion; D007422:Intestines / Q000382:microbiology*; D008565:Membrane Proteins / Q000494:pharmacology; D016254:Mutagenesis, Insertional; D019081:O Antigens / Q000235:genetics / Q000502:physiology; D011817:Rabbits; D014161:Transduction, Genetic; D014534:UDPglucose 4-Epimerase / Q000235:genetics* / Q000502:physiology; D005957:UTP-Glucose-1-Phosphate Uridylyltransferase / Q000235:genetics* / Q000502:physiology; D037521:Virulence Factors / Q000235:genetics / Q000502:physiology
D000900:Anti-Bacterial Agents; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D029968:Escherichia coli Proteins; D008565:Membrane Proteins; D019081:O Antigens; D037521:Virulence Factors; C021623:bactericidal permeability increasing protein; D005957:UTP-Glucose-1-Phosphate Uridylyltransferase; C121039:galU protein, E coli; D014534:UDPglucose 4-Epimerase; C020551:galactose epimerase